| Primary |
| Dyslipidaemia |
33.3% |
| Erysipelas |
22.2% |
| Angina Pectoris |
11.1% |
| Anxiety |
11.1% |
| Pain |
11.1% |
| Product Used For Unknown Indication |
11.1% |
|
| Condition Aggravated |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
31.2% |
| Product Used For Unknown Indication |
14.0% |
| Ill-defined Disorder |
12.9% |
| Angina Pectoris |
11.8% |
| Coronary Artery Disease |
4.3% |
| Hypertension |
4.3% |
| Arteriogram Coronary |
2.2% |
| Deep Vein Thrombosis |
2.2% |
| Erysipelas |
2.2% |
| Hepatitis C |
2.2% |
| Pancreatic Carcinoma |
2.2% |
| Psychotic Disorder |
2.2% |
| Acute Myocardial Infarction |
1.1% |
| Anxiety |
1.1% |
| Breast Cancer |
1.1% |
| Bronchial Carcinoma |
1.1% |
| Delirium |
1.1% |
| Dyslipidaemia |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Lung Adenocarcinoma |
1.1% |
|
| Orthostatic Hypotension |
14.6% |
| Hyponatraemia |
9.8% |
| Pemphigoid |
9.8% |
| Intentional Overdose |
7.3% |
| Rash Macular |
7.3% |
| Renal Failure Acute |
7.3% |
| Lung Neoplasm |
4.9% |
| Tremor |
4.9% |
| Ventricular Tachycardia |
4.9% |
| Weight Decreased |
4.9% |
| Blood Creatinine Increased |
2.4% |
| Dehydration |
2.4% |
| Disorientation |
2.4% |
| Electrocardiogram Qt Prolonged |
2.4% |
| Fall |
2.4% |
| Hyperaesthesia |
2.4% |
| International Normalised Ratio Increased |
2.4% |
| Microcytic Anaemia |
2.4% |
| Polyneuropathy |
2.4% |
| Pulmonary Hypertension |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.4% |
| Product Used For Unknown Indication |
17.5% |
| Hypertension |
9.4% |
| Myocardial Infarction |
6.8% |
| Acute Coronary Syndrome |
6.0% |
| Diabetes Mellitus |
4.0% |
| Stent Placement |
4.0% |
| Prophylaxis |
3.7% |
| Ill-defined Disorder |
3.4% |
| Coronary Artery Disease |
2.9% |
| Angina Pectoris |
2.5% |
| Bronchitis |
2.2% |
| Coronary Artery Insufficiency |
2.2% |
| Myocardial Ischaemia |
2.2% |
| Dyslipidaemia |
1.9% |
| Osteoporosis |
1.4% |
| Urinary Tract Infection |
1.4% |
| Angina Unstable |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Atrial Fibrillation |
0.9% |
|
| Dyspnoea |
8.4% |
| Myocardial Infarction |
7.5% |
| Peripheral Sensory Neuropathy |
7.5% |
| Pyrexia |
6.5% |
| Sudden Death |
6.5% |
| Cardiac Failure |
5.6% |
| Renal Failure Acute |
5.6% |
| Cardiac Arrest |
4.7% |
| Pulmonary Embolism |
4.7% |
| Vertigo |
4.7% |
| Vomiting |
4.7% |
| Cerebrovascular Accident |
3.7% |
| Death |
3.7% |
| Erythema Multiforme |
3.7% |
| Fixed Eruption |
3.7% |
| General Physical Health Deterioration |
3.7% |
| Hypogammaglobulinaemia |
3.7% |
| Lung Infection |
3.7% |
| Lung Neoplasm Malignant |
3.7% |
| Malaise |
3.7% |
|
| Interacting |
| Ill-defined Disorder |
90.9% |
| Angina Pectoris |
9.1% |
|
| Loss Of Consciousness |
33.3% |
| Orthostatic Hypotension |
33.3% |
| Vertigo |
33.3% |
|
